Elixirgen Scientific Achieves ISO 9001 QMS Certification

Baltimore-based biotech company Elixirgen Scientific, Inc. has been certified with the ISO 9001:2015 standard, a global benchmark in Quality Management Systems (QMS). This accreditation marks a significant step for the firm, emphasizing its dedication to quality and excellence in biotechnology and drug discovery fields. The ISO 9001:2015 certification underscores the company's commitment to developing products and services that meet customer requirements efficiently.

Elixirgen Scientific specializes in advancing drug discovery and cell therapy innovations using iPSC technology. The ISO 9001:2015 certification assures that their iPSC-derived cells and services adhere to the highest standards of quality management. This certification is expected to enhance the reliability and efficacy of Elixirgen's offerings for research and therapeutic applications, including their Quick-Glia™ iPSC-derived astrocytes and custom differentiation services.

The company underwent an extensive audit by QAS International, focusing on product lifecycle management, service and product design, and development practices, leading to the awarding of the ISO certification. Elixirgen Scientific's certification is set to ensure continuous improvement, effective risk management, and customer satisfaction, reinforcing its position as a biotechnology pioneer.